Abstract
The cardiovascular effects are dose-related. Low doses can cause transient bradycardia; moderate or high doses can cause tachycardia, palpitation, and arrhythmias (due to blockage of vagal effects on the S-A node).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Readings
Hall R. C. W., Feinsilver D. L., Holt R. E.: Anticholinergic psychosis: Differential diagnosis and management. Psychosomatics 22: 581–587, 1981.
Hiatt R. L., Fuller I. B., Smith L., et al: Systemically administered anticholinergic drugs and intraocular pressure. Arch Ophthalmol 84: 735–740, 1970.
Lamy P. P.: Update on antiparkinsonian agents. Geriatr Pharmacol 37: 8191, 1982.
Shimomura S. K., Siepler J. K.: Parasympatholytic cholinergic blocking agents in Knoben J. E., Anderson P. O. (eds): Handbook of Clinical Drug Data, 5th ed. Hamilton, Illinois, Drug Intelligence Publications, 1983, pp 376–378.
Van der Kolk B. A., Shader R. I., Greenblatt D. J.: Autonomic effects of psychotropic drugs, in Lipton M. A., DiMascio A., Killam K. F. (eds): Psychopharmacology: A Generation of Progress, 2nd ed. New York, Raven Press, 1978, pp 1009–1020.
Weiner N.: Atropine, scopolamine, and related antimuscarine drugs, in Gilman A. G., Goodman L. S., Rall T. W., Murad F. (eds): The Pharmacological Basis of Therapeutics; 7th ed. New York, Macmillan, 1985, pp 130–144.
Zaratzian V. L.: Drug-induced dysfunctions of the autonomic nervous system, in Blum K., Manzo L. (eds): Neurotoxicology. New York, Marcel Dekker, 1985, pp 69–81.
Goggin D. A., Solomon G. F.: Trihexyphenidyl abuse for euphorigenic effect. Am J Psychiatry 136: 459–460, 1979.
Jellinek T.: Mood elevating effect of trihexyphenidyl and biperiden in individuals taking antipsychotic medication. Dis New Syst 38: 353–355, 1977.
Jellinek T., Gardos G., Cole J. O.: Adverse effects of antiparkinson drug withdrawal. Am J Psychiatry 138: 1567–1571, 1981.
MacVicar K.: Abuse of antiparkinsonian drugs by psychiatric patients. Am J Psychiatry 134: 809–811, 1977.
Rubinstein J. S.: Abuse of antiparkinson drugs. J Am Med Assoc 239: 2365–2366, 1978.
Briggs G. G., Bodendorfer T. W., Freeman R. K., et al: Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Baltimore, Williams & Wilkins, 1983.
Heironen O. P., Slone D., Shapiro S. (eds): Birth Defects and Drugs in Pregnancy. Littleton, Massachusetts, Publishing Sciences Group, 1977.
Omnis A., Grella P. (eds): The Biochemical Effects of Drugs in Pregnancy, Vol I. New York, John Wiley, 1984.
The Royal Women’s Hospital Reference Guide on Drugs in Pregnancy. Carlton, Victoria, R. Batagol, 1983.
Flaherty J. A., Bellur S. N.: Mental side effects of amantadine therapy: Its spectrum and characteristics in a normal population. J Clin Psychiatry 42 (9): 344–345, 1981.
Simpson D. M., Davis G. C.: Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine. Am J Psychiatry 141: 796–797, 1984.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Publishing Corporation
About this chapter
Cite this chapter
Tornatore, F.L., Sramek, J.J., Okeya, B.L., Pi, E.H. (1987). Reactions to Antiparkinson Agents. In: Reactions to Psychotropic Medication. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5412-3_6
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5412-3_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5414-7
Online ISBN: 978-1-4684-5412-3
eBook Packages: Springer Book Archive